We combine our long biomaterials expertise with the power of proprietary manufacturing platform to develop novel hemostatic, surgical and wound care products. Current area of focus is in improving patient outcomes in pre-hospital, intra-operative, and post-operative clinical settings.
US FDA granted 510(k) clearance to Axiostat Gauze, which is intended for use as a temporary external dressing to control moderate to severe bleeding and manage external abrasions, lacerations.
Also as an over-the-counter product for the local management of bleeding wounds such as minor cuts, lacerations, and abrasions.
Ax-Surgi is the first FDA-cleared chitosan-based surgical hemostat intended for the temporary control of internal organ space bleeding in patients displaying class III or IV bleeding. In the US, the product will be marketed by Advamedica Inc, headquartered in Boston.
Meet us at LSI USA Emerging Medtech Summit 2023, at Dana Point, California from 20th March to 23rd March. LSI USA 2023 is one of the largest medtech partnering event which sees participation of leading medtech startup CEOs, innovators, investors, and industry leaders.
Stop by our booth # 941 at the EMS World Expo 2022 for live Axiostat demonstration on Blood Faster Hemostasis.
Como to visit us for a live demo on:
Meet us at VIVA in Las Vegas from October 31th to November 3rd, 2022.
VIVA22 will continue to define innovation in vascular medicine and intervention, featuring a world-renowned, multispecialty faculty; extended concurrent and pre-course sessions; state-of-the-art technology; and an unmatched spirit of collegiality and camaraderie.
Visit us at the booth # 210
Meet us at The VEINS (Venous Endovascular Interventional Strategies) in Las Vegas from October 30 to 31, 2022. A transformative multidisciplinary educational event dedicated to diagnosing, intervening and managing venous disorders. Come to explore key clinical topics, current practice trends, and a glimpse of what’s next in venous disease care.
Visit us at the booth # 210
President
Business Manager - North America
Associate Professor of Medicine Harvard Medical School
Professor of Emergency Medicine Stanford University Medical Centre
© Advamedica Inc 2024. All Rights Reserved
Accomplished Medical Sales Professional with a 20 year record of growing markets, increasing product penetration and leading high performance sales teams in hemostat business. Previously Phil was Vice President at Core Scientific and spent a decade at ZMedica, a leading hemostat company as Regional Sales Director. Phil has a business management degree from Florida State University.
Dr. Mahadevan is a Professor of Emergency Medicine at Stanford University where he has been a recipient of numerous teaching awards. He also serves as the Director of Global Affairs and Strategy for Stanford Medicine. He received his medical degree from David Geffen School of Medicine at UCLA.
Dr. Sengupta serves as the Associate Professor of Medicine at HMS and as the Associate Professor of Health Sciences and Technology at MIT. Dr. Sengupta received his PhD from University of Cambridge as a British Chevening and Nehru Scholar, and is a recipient of the TR35 Innovator Award from the MIT Technology Review Magazine and the Era of Hope Scholar Award from the US Department of Defense.
Satish brings a wealth of diverse experiences to his CFO role at Advamedica. In addition to his Fortune 500 roles (FedEx, Citi, AmEx, JPM Chase) in various leadership capacities across multiple countries, he has worked with a number of startups and SMBs as their in-house or consulting CFO. Over the last three years, Satish has helped companies raise over $100 million in venture capital and financing.
Quality professional with over 25 years of experience in the medical device, pharmaceutical, and software industries.
Maria is specialized in developing and implementing Quality Management Systems and has deep knowledge and experience in audit preparation, resolution/remediation as per regulatory compliance in ISO 13485, 21 CFR Part 820, EU MDR, MDSAP, and other regional regulations (China, Taiwan, Brazil, Japan, Canada, Australia, Korea, Switzerland, etc.)
Samantha is Director of Clinical Marketing at Advamedica. Previously she was Global Training Manager in Terumo Aortic overseeing all training and clinical skills. Prior to that Samantha was National Sales & Marketing Manager in Bolton Medical, Italy for almost a decade. Samantha has done Executive MBA in Strategic Marketing and has Degree in Professional nursing from the University of Bologna, Italy.
Edward is US – National Sales Director at Advamedica. He comes with many decades of experience selling novel hemostats and woundcare products in over 26 states in the US. He was earlier Regional Sales Director at Z-Medica managing business of their Hemostatic product line for Surgery, Trauma, Cardiology, Burn and Wound Care. He is passionate about creating top performing teams, driven by diversity, inclusion, values and accountability. Edward has a Bachelor of Business Administration from Dowling College.
Oscar Rospigliosi is a Senior MedTech executive with broad experience in medical device sales and marketing. He was the CEO & Director at Scion Biomedical and prior to that, he was a CEO at Bolton Medical Group, guiding the company from $4.5mn in annual revenues to $80mn in the cardio-thoracic market.
Leo Mavely is the president of Advamedica Inc. He is passionate about medtech innovations for unmet healthcare needs, and has been featured by Fortune Magazine in 40 under 40 business leaders and by Entrepreneur Magazine in 35 under 35 Game-Changing Entrepreneurs. He holds a Bachelor’s degree in Bioengineering.
